QuickGun LifeScience

Phytochemical based Therapy for Covid taste loss disorder and inflammation

Posted by Subramani from QuickGun LifeScienceResponsive · Innovative Products and Technologies · India

Summary of the technology

Our team of scientists have developed a pytochemical formulation for Covid which reduces viral load and inflammation. Its is useful in taste loss disorder. Its a combination of CBD-THC and a plant based alkaloid. They have safety profile of over 40 years. We have successfully formulated a rotocap based delivery system. We need strategic partners.

Description of the technology

Please connect with us for more details

Intellectual property status

Patent already applied for

Patent application number : 202021029007

Where : India

Technology Owner

Subramani Naidu

Promoter at QuickGun LifeScience

Related keywords

  • Biological Sciences
  • Protecting Man and Environment
  • Genetic Engineering / Molecular Biology
  • Covid-19
  • covid

About QuickGun LifeScience

Startup from India

R&D company focused on holding intellectual proprties and brands.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.